Global Gingivitis Treatment Market Projected to Reach USD 11.19 Billion by 2033 at a 4.8% CAGR, Driven by Rising Oral Health Awareness and Technological Advancements

Global Gingivitis Treatment Market

The global gingivitis treatment market, valued at USD 7 billion in 2023, is forecasted to grow at a steady CAGR of 4.8% over the next decade, reaching approximately USD 11.19 billion by 2033. This growth is attributed to the increasing prevalence of gum disease, heightened awareness about oral health, and the continuous introduction of innovative treatment products and technologies. From 2018 to 2022, the market experienced a CAGR of 3.2%, reflecting the steady demand for effective gingivitis treatments.

Gingivitis, an inflammation of gum tissue surrounding the teeth, is a common condition that can lead to more severe oral health issues if untreated. The gingivitis treatment market includes a wide array of products and services, ranging from therapeutic mouthwashes and toothpastes to advanced dental care procedures, all aimed at reducing inflammation and promoting gum health.

With growing investments in research and the development of more efficient treatment solutions, the market is set to offer improved options for managing gingivitis, enhancing oral health, and preventing progression to more serious gum diseases on a global scale.

What are the Challenges Faced by the Gingivitis Treatment Market?

Expensive Cost of Treatment to restrict Market Growth

Despite the growing awareness of the importance of maintaining good oral health, many people still lack awareness of gum disease and its treatment options. This can limit demand for gingivitis treatment products and services.

Additionally, the cost of gingivitis treatment can be a barrier for many people, particularly those without insurance coverage. This can limit demand for treatment options and make it more challenging for companies to generate revenue..

Companies operating in the gingivitis treatment market must comply with regulatory requirements related to product safety and efficacy. This can be challenging and costly, particularly for smaller companies without significant resources. Overall, companies operating in the gingivitis treatment market must navigate these challenges to capture market share and drive growth. By developing innovative products, building strong brands, and effectively communicating the benefits of their offerings, companies can overcome these challenges and succeed in this market.

Market Competition

Key players in the market include companies such as Fibrocell Sciences, Tolmar Inc., Eli Lilly & Company, Align Technology, Dentsply International, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Orapharma, Kaken Pharmaceutical, and Valeant Pharmaceuticals Int., along with healthcare providers and technology companies among other global players.

• In October 2022, it was announced that a rapid test for gum disease is being developed by researchers at the University of Birmingham. The probe, designed for use in point-of-care settings such as dental surgeries or pharmacies, is expected to aid in the early detection of heart or lung disease, type 2 diabetes, and rheumatoid arthritis. A new technique developed by Professor Tim Albrecht from the School of Chemistry and Dr Melissa Grant from the School of Dentistry at the University provides a swift and accurate assessment of gum disease using a sample of saliva, which can be collected in any healthcare setting.

The technique involves a specialized probe and detector that provide quantitative measurements of biomarkers indicating the presence and severity of gum disease. These biomarkers were validated and identified by the university’s Periodontal Research Group and published in the Journal of Clinical Periodontology earlier this year. The researchers have secured funding from the EPSRC Impact Acceleration Account to create a prototype of the device, which is expected to be launched within a year.

Key Companies Profiled

Fibrocell Sciences, Tolmar Inc., Eli Lilly & Company, Align Technology, Dentsply International, 3M Company, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Orapharma, Kaken Pharmaceutical, and Valeant Pharmaceuticals Int.

A Full Report Overview

Key Segments Profiled in the Gingivitis Treatment Industry Survey

Drug Class:

• Veetids
• Erythrocin
• Minocycline
• Doxycycline
• Clindamycin
• Chlorhexidine
• Acetaminophen
• Ibuprofen
• Lidocaine

Route of Administration:

• Oral
• Topical

End-User:

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube